Global Antifungals Market Report 2021: Market is Expected to Reach $13.71 Billion in 2025 - Long-term Forecast to 2030

DUBLIN, Aug. 13, 2021 /PRNewswire/ -- The "Antifungals Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering.

The global antifungals market is expected to grow from $9.98 billion in 2020 to $10.29 billion in 2021 at a compound annual growth rate (CAGR) of 3.1%. The market is expected to reach $13.71 billion in 2025 at a CAGR of 7.4%.

Major players in the antifungals market are Pfizer, Novartis, Merck & Co., Bayer Healthcare and Abbott Laboratories.

The antifungals market consists of sales of antifungal drugs which are used to detect and eliminate fungal pathogens. The fungal pathogens thrive in the body under unhygienic and unclean environments. These drugs are also known as an antimycotic medication, used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis (thrush), serious systemic infections such as cryptococcal meningitis, and others.

Drug developers and manufacturers are scaling up the various departments such as research and development, marketing, and manufacturing through collaborations and strategic partnerships with other companies and research institutes, to expand the product portfolios. So, companies in the anti-infective drugs market should consider strategic collaborations to broaden their scope and product portfolios to increase the revenues and stay competitive in the market.

A point prevalence survey was conducted in Turkey. According to the survey, antifungal drugs were mostly prescribed in pediatric hematology and oncology (PHO) units (35.2%), followed by neonatal ICUs (NICUs) (19.6%). The other units prescribing antifungal drugs included pediatric services (18.3%), pediatric ICUs (PICUs) (14.6%) and hematopoietic (HSCT) units (7.3%).

According to the same survey, the antifungals were used for prophylaxis in 48.8% of patients and about 50% of patients were treated with antifungal drugs based on observation. Among 50% of patients, who were treated post observation, around 18.8% of patients were prescribed an antifungal therapy and 31.2% of patients were targeted for the treatments.

Antifungal drugs manufacturers are offering skimming price for branded drugs. The discovery, development and manufacturing processes of branded drugs generally require high investments. As a result, companies in the market offer the branded drugs at the highest initial prices, and implement other pricing strategies to ensure the product stays competitive at a high price.

Price skimming is a pricing strategy in which a company charges a high initial price and then gradually lowers the price to attract more price-sensitive customers. It is used to maximize profits when a new product is introduced in the market.

Manufacturers and marketers of branded drugs should consider adopting the price skimming strategy for branded drugs. They should price these branded drugs high to recover the high costs incurred during drug development and manufacturing.

Key Topics Covered:

1. Executive Summary

2. Antifungals Market Characteristics

3. Antifungals Market Trends And Strategies

4. Impact Of COVID-19 on Antifungals

5. Antifungals Market Size And Growth
5.1. Global Antifungals Historic Market, 2015-2020, $ Billion
5.1.1. Drivers of the Market
5.1.2. Restraints on The Market
5.2. Global Antifungals Forecast Market, 2020-2025F, 2030F, $ Billion
5.2.1. Drivers of the Market
5.2.2. Restraints on the Market

6. Antifungals Market Segmentation
6.1. Global Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Echinocandins
• Azoles
• Polyenes
• Allylamines

6.2. Global Antifungals Market, Segmentation End users, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Hospitals & Clinics
• Dermatology clinics
• Other Users

6.3. Global Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Oral
• Parenteral
• Topical

6.4. Global Antifungals Market, Segmentation By Therapeutic Indications, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Aspergillosis
• Dermatophytosis
• Candidiasis
• Others

7. Antifungals Market Regional And Country Analysis
7.1. Global Antifungals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
7.2. Global Antifungals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

• Pfizer
• Novartis
• Merck & Co.
• Bayer Healthcare
• Abbott Laboratories
• Sanofi-Aventis
• Kramer Laboratories
• Glaxosmithkline Gilead
• Enzon Pharmaceuticals Inc.
• Basilea Pharmaceutica AG
• PerkinElmer
• Alternaria
• Sigma-Aldrich
• Astellas Pharma Inc.
• Janssen Pharmaceutica NV
• Zydus Cadila Healthcare Ltd.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Sumitomo Dainippon Pharma Co. Ltd.
• Scynexis Inc.
• Mayne Pharma Inc.
• Cosmo Pharmaceuticals NV

For more information about this report visit https://www.researchandmarkets.com/r/ndaxvc

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/global-antifungals-market-report-2021-market-is-expected-to-reach-13-71-billion-in-2025---long-term-forecast-to-2030--301354993.html

SOURCE Research and Markets